Spectator on facebook

Spectator on facebook

MVK Survey: Expensive medicine biggest health care problem

According to the results of the latest survey conducted by the MVK agency on a sample of 1,200 adults, 80 percent of the respondents think that the biggest problem in Slovakia's health care sector at the moment is expensive medicines, it was reported on September 12.

Only 29.6 percent of the questioned expressed their support for Health Minister Ivan Valentovič, while 27.7 percent are against health insurance companies being allowed to make profits, and 26 percent said that they have experienced problems with the quality of health care.

The survey also showed that 47 percent are worried that the rich are becoming richer and the poor poorer. Meanwhile, 45 percent of the respondents view high living costs as their main problem, and 35.7 percent are concerned about a perceived high level of crime. Unemployment and a lack of job opportunities is a problem according to 35.6 percent of the respondents.

Cronyism and bribery worries 21.6 percent, while the levels of pensions and care for the elderly were viewed as a problem by only 19 percent. Categories with dissatisfaction levels of below 10 percent were the economy, the environment, and the quality of democracy in Slovakia. Less than 2 percent of the respondents said that they are worried about the situation of minorities. TASR

Compiled by Zuzana Vilikovská from press reports
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.

Top stories

Jaguar plant in Nitra will be bigger

The carmaker plans to add a new facility and employ more people.

Jaguar Land Rover plant near Nitra is under construction

Government members met at a distance

The session had only one point on its programme: the mandate for the prime minister to meet with the French president.

It’s not easy to be friends with Fico

Will Andrej Danko take the government down with him?

Andrej Danko

Bankers adjust to customers’ habits

More people will be coming to banks for advisory.